Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3238/arztebl.2017.0197 http://scihub22266oqcxt.onion/10.3238/arztebl.2017.0197 C5397890!5397890!28407841     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Dtsch+Arztebl+Int 2017 ; 114 (12): 197-203 Nephropedia Template TP {{tp|p=28407841|t=2017. Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions |pdf=|usr=}}{{28407841}} gab.com Text Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions JO: Dtsch Arztebl Int http://www.kidney.de/pget.php?&tw=1&pmid=28407841 #FOAvip Background: Approximately 1.5 million adults in Germany suffer from an inflammatory rheumatological condition. The most common among these are rheumatoid arthritis and spondyloarthritis?above all axial spondyloarthritis, including ankylosing spondylitis (Bekhterev?s disease) and psoriatic arthritis. These systemic inflammatory diseases often affect the heart as well. Methods: This review is based on pertinent articles retrieved by a selective literature search, on current European guidelines, and on the authors? clinical experience. Results: Rheumatic inflammation of cardiac structures can manifest itself as pericarditis, myocarditis, or endocarditis. The heart valves and the intracardiac conduction system can be affected as well, leading to AV block. Functional sequelae, e.g., congestive heart failure, can arise as a consequence of any inflammatory rheumatic disease. The long-term mortality of rheumatic diseases is elevated predominantly because of the increased risk for cardiovascular comorbidities. The cardiovascular risk profile should therefore be re-evaluated regularly (e.g., at 5-year intervals) in cooperation with the patient?s primary care physician. The cardiovascular manifestations of rheumatic disease, such as pericarditis, myocarditis, and vasculitis, are treated initially with high-dose glucocorticoids and then over the long term with maintenance drugs such as methotrexate and azathioprine. Biological agents are sometimes used as well. Conclusion: In patients with inflammatory rheumatic diseases, the elevated cardiovascular risk should be kept in mind and preventive measures should be initiated early. This subject should be further studied in controlled trials so that the treatment options for patients with cardiac involvement can be evaluated. Twit Text FOAVip Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions ????Dtsch Arztebl Int http://www.kidney.de/pget.php?&tw=1&pmid=28407841 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28407841 #FOAvip English Wikipedia <ref>{{Cite pmid|28407841}}</ref> Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions #MMPMID28407841 Braun J; Krüger K; Manger B; Schneider M; Specker C; Joachim Trappe H Dtsch Arztebl Int 2017[Mar]; 114 (12): 197-203 PMID28407841show ga Background: Approximately 1.5 million adults in Germany suffer from an inflammatory rheumatological condition. The most common among these are rheumatoid arthritis and spondyloarthritis?above all axial spondyloarthritis, including ankylosing spondylitis (Bekhterev?s disease) and psoriatic arthritis. These systemic inflammatory diseases often affect the heart as well. Methods: This review is based on pertinent articles retrieved by a selective literature search, on current European guidelines, and on the authors? clinical experience. Results: Rheumatic inflammation of cardiac structures can manifest itself as pericarditis, myocarditis, or endocarditis. The heart valves and the intracardiac conduction system can be affected as well, leading to AV block. Functional sequelae, e.g., congestive heart failure, can arise as a consequence of any inflammatory rheumatic disease. The long-term mortality of rheumatic diseases is elevated predominantly because of the increased risk for cardiovascular comorbidities. The cardiovascular risk profile should therefore be re-evaluated regularly (e.g., at 5-year intervals) in cooperation with the patient?s primary care physician. The cardiovascular manifestations of rheumatic disease, such as pericarditis, myocarditis, and vasculitis, are treated initially with high-dose glucocorticoids and then over the long term with maintenance drugs such as methotrexate and azathioprine. Biological agents are sometimes used as well. Conclusion: In patients with inflammatory rheumatic diseases, the elevated cardiovascular risk should be kept in mind and preventive measures should be initiated early. This subject should be further studied in controlled trials so that the treatment options for patients with cardiac involvement can be evaluated. äCardiovascular Comorbidity in Inflammatory Rheumatological Conditions (epmc).pdf DeepDyve Pubget Overpricing